Flagship-Backed Tessera Raises $300 Million for Gene-Fixing TechApril 19, 2022/in NEWS /by March Capital https://marchcp.com/wp-content/uploads/2022/03/Tessera_forweb.png 380 480 March Capital https://marchcp.com/wp-content/uploads/2020/11/MC__Logo.png March Capital2022-04-19 10:57:462022-04-19 11:01:17Flagship-Backed Tessera Raises $300 Million for Gene-Fixing Tech